These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8543957)

  • 1. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
    Daniels SR; Hudson JI; Horwitz RI
    J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
    Horwitz RI; Daniels SR
    J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    Kilbourne EM; Philen RM; Kamb ML; Falk H
    J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome.
    Milburn DS; Myers CW
    DICP; 1991 Nov; 25(11):1259-62. PubMed ID: 1763543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.
    Kamb ML; Murphy JJ; Jones JL; Caston JC; Nederlof K; Horney LF; Swygert LA; Falk H; Kilbourne EM
    JAMA; 1992 Jan; 267(1):77-82. PubMed ID: 1727200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-tryptophan and the eosinophilia-myalgia syndrome.
    Drug Ther Bull; 1990 May; 28(10):37-8. PubMed ID: 2131206
    [No Abstract]   [Full Text] [Related]  

  • 9. L-tryptophan and eosinophilia-myalgia syndrome.
    Shapiro S
    Lancet; 1994 Apr; 343(8904):1035-7. PubMed ID: 7909063
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of L-tryptophan and eosinophilia-myalgia syndrome.
    Roufs JB
    J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of the eosinophilia-myalgia syndrome.
    Clauw DJ
    J Rheumatol Suppl; 1996 Oct; 46():93-7; discussion 92, 97-8. PubMed ID: 8895185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilia-myalgia syndrome in Germany: an epidemiologic review.
    Carr L; Rüther E; Berg PA; Lehnert H
    Mayo Clin Proc; 1994 Jul; 69(7):620-5. PubMed ID: 8015323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilia myalgia syndrome.
    Blackburn WD
    Semin Arthritis Rheum; 1997 Jun; 26(6):788-93. PubMed ID: 9213377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilia-myalgia syndrome: lessons for public health researchers.
    Taylor R; McNeil JJ
    Med J Aust; 1993 Jan; 158(1):51-5. PubMed ID: 8380218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
    Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
    J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
    Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM
    Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
    Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM
    J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
    André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
    Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
    Mizutani T; Mizutani H; Hashimoto K; Nakamura Y; Kishida M; Taniguchi H; Murata M; Kuzuhara S; Shimizu M
    J Am Acad Dermatol; 1991 Sep; 25(3):512-7. PubMed ID: 1918490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.